Ethics in HIV Pre-Exposure Prophylaxis Trials
Author Information
Author(s): Kokolo Madzouka B., Fergusson Dean A., Cameron D. William
Primary Institution: Ottawa Hospital Research Institute, Clinical Epidemiology Programme, Ottawa, Ontario, Canada
Hypothesis
How well are ethics considerations reported in HIV pre-exposure prophylaxis (PrEP) study documents?
Conclusion
The study found that, on average, 58% of ethics items were reported in PrEP study documents, indicating significant room for improvement.
Supporting Evidence
- 58% of ethics items were reported on average across the studies.
- Social value considerations were the least reported at 43%.
- Informed consent and favorable risk-benefit ratio were the most reported at 75%.
Takeaway
This study looked at how well researchers talk about ethics when doing HIV prevention trials, and found that they could do a better job at it.
Methodology
A systematic quantitative ethics appraisal was conducted using a checklist of 101 evidence-based ethics items across 11 PrEP study documents.
Potential Biases
Potential bias due to the limited range of documents analyzed and the varying stages of document revisions.
Limitations
The checklist was developed without extensive expert consultation, and the analysis did not evaluate the actual conduct of the trials.
Participant Demographics
The trials included diverse populations such as heterosexual couples, women, and men who have sex with men across various countries.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website